Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Isuprel
Active Ingredient: Isoprenaline hydrochloride 200mcg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Hospira NZ Limited
Manufacturers: Abbott Laboratories Srl, Latina, Italy
Hospira SpA, Milano, Italy
Hospira Inc, Kansas, United States of America
Dated this 24th day of April 2014.
DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).